Hamers, P.A.H.; Wensink, G.E.; van Smeden, M.; Vink, G.R.; Smabers, L.P.; Lunenberg, R.A.; Laclé, M.M.; Koopman, M.; May, A.M.; Roodhart, J.M.L.
External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice. Cancers 2022, 14, 5094.
https://doi.org/10.3390/cancers14205094
AMA Style
Hamers PAH, Wensink GE, van Smeden M, Vink GR, Smabers LP, Lunenberg RA, Laclé MM, Koopman M, May AM, Roodhart JML.
External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice. Cancers. 2022; 14(20):5094.
https://doi.org/10.3390/cancers14205094
Chicago/Turabian Style
Hamers, Patricia A. H., G. Emerens Wensink, Maarten van Smeden, Geraldine R. Vink, Lidwien P. Smabers, Renee A. Lunenberg, Miangela M. Laclé, Miriam Koopman, Anne M. May, and Jeanine M. L. Roodhart.
2022. "External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice" Cancers 14, no. 20: 5094.
https://doi.org/10.3390/cancers14205094
APA Style
Hamers, P. A. H., Wensink, G. E., van Smeden, M., Vink, G. R., Smabers, L. P., Lunenberg, R. A., Laclé, M. M., Koopman, M., May, A. M., & Roodhart, J. M. L.
(2022). External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice. Cancers, 14(20), 5094.
https://doi.org/10.3390/cancers14205094